Vividion Therapeutics Stock

vividion.comHealthcareFounded: 2017Funding to Date: $267.82MM

Vividion Therapeutics is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.

Register for Details

For more details on financing and valuation for Vividion Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Vividion Therapeutics.

Register Today


Management Team

Trisha Millican
Chief Financial Officer
Benjamin Cravatt Ph.D
Scientific Co-Founder & Board Member
Diego Miralles MD
Chief Executive Officer & Board Member
Jin-Quan Yu Ph.D
Scientific Co-Founder
Fred Aslan MD
President & Chief Business Officer
Phil Baran Ph.D
Scientific Co-Founder

Board Members

Thomas Daniel MD
Richard Heyman Ph.D
Kristina Burow
ARCH Venture Partners
Thomas Woiwode Ph.D
Versant Venture Management
Jakob Loven Ph.D
Nextech Invest
Benjamin Cravatt Ph.D
Paul Schimmel Ph.D
John Clarke
Cardinal Partners
Diego Miralles MD

Other companies like Vividion Therapeutics in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


Company says it's leading a resurgence of traditional small-molecule drugs